A proteome-scale reverse screening approach reveals multi-target interactions of anthraquinone derivatives in cancer-related pathways.
Cancer is a multifactorial and heterogeneous disease in which single-target therapeutic strategies often fail to achieve sustained efficacy. Anthraquinone derivatives exhibit diverse anticancer activities; however, their comprehensive molecular targets and mechanisms of action remain incompletely characterized. In this...